The real-life early and continuative response to Galcanezumab in chronic migraine: 3-month analysis of the multicenter prospective cohort GARLIT study

被引：0

作者：

Altamura, C. ^{[1
]}

Brunelli, N. ^{[1
]}

Costa, C. M. ^{[1
]}

Aurilia, C. ^{[2
]}

Egeo, G. ^{[2
]}

Fofi, L. ^{[2
]}

Favoni, V. ^{[3
]}

Pierangeli, G. ^{[3
]}

Messina, R. ^{[4
]}

Filippi, M. ^{[4
]}

Colombo, B. ^{[4
]}

Lovati, C. ^{[5
]}

Aguggia, M. ^{[6
]}

Bertuzzo, D. ^{[6
]}

D'Onofrio, F. ^{[7
]}

Doretti, A. ^{[8
,9
]}

Di Fiore, P. ^{[10
]}

Frediani, F. ^{[10
]}

Finocchi, C. ^{[11
]}

Rao, R. ^{[12
]}

Di Cola, F. Schiano

Bono, F. ^{[13
]}

Ranieri, A. ^{[14
]}

Albanese, M. ^{[15
]}

Cevoli, S. ^{[3
]}

Barbanti, P. ^{[2
]}

Vernieri, F. ^{[1
]}

机构：

[1] Campus Biomed Univ Rome, Neurol, Rome, Italy

[2] IRCCS San Raffaele Pisana, Headache & Pain Unit, Rome, Italy

[3] IRCCS Ist Sci Neurol Bologna, Bologna, Italy

[4] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Neurol Unit, Milan, Italy

[5] Univ Hosp L Sacco, Neurol Unit, Milan, Italy

[6] Asti Hosp, Neurol & Stroke Unit, Asti, Italy

[7] Giuseppe Moscati Hosp, Neurol Unit, Avellino, Italy

[8] IRCCS, Ist Auxol Italiano, Stroke Unit, Neurol, Milan, Italy

[9] Lab Neurosci, Milan, Italy

[10] San Carlo Borromeo Hosp, ASST Santi Paolo & Carlo Milan, Headache Ctr, Neurol & Stroke Unit, Milan, Italy

[11] Osped Policlin San Martino, IRCCS, Genoa, Italy

[12] Univ Brescia, Dept Clin & Expt Sci, Neurol Unit, Brescia, Italy

[13] AOU Mater Domini, Neurol Unit, Catanzaro, Italy

[14] A Cardarelli Hosp, Headache Ctr, Neurol & Stroke Unit, Naples, Italy

[15] Univ Hosp Rome Tor Vergata, Dept Syst Med, Rome, Italy

来源：

JOURNAL OF HEADACHE AND PAIN | 2021年 / 22卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P0343

引用

页码：123 / 123

页数：1

共 50 条

[41] Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
Piero Barbanti
Gabriella Egeo
Cinzia Aurilia
Florindo d’Onofrio
Maria Albanese
Ilaria Cetta
Paola Di Fiore
Maurizio Zucco
Massimo Filippi
Francesco Bono
Claudia Altamura
Stefania Proietti
Stefano Bonassi
Fabrizio Vernieri
The Journal of Headache and Pain, 2022, 23
[42] An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
Ahmed, Fayyaz
Gaul, Charly
Garcia-Monco, Juan Carlos
Sommer, Katherine
Martelletti, Paolo
Afanador, Lauriaselle
Franznick, Dana
Asmus, Peter
Becker, Veit
Boeger, Andrea
Buschmann, Dirk
Dulcius, Andrea
Ebke, Markus
Engelmann, Christoph
Eser, Anna-Katharina
Foerster, Heike
Freitag, Frank
Gaul, Charly
Gendolla, Astrid
Gerlach, Klaus
Gessler, Martin
Goebel, Hartmut
Guenther, Olaf
Halbgewachs, Frank
Hamacher, Juergen
Haendel, Dorothea
Haslbeck, Matthias
Heinicke, Volker
Hellwig, Bernhard
Herbst, Heinz Peter
Hesselbarth, Sabine
Jaeger, Hanno
Jansen, Jan-Peter
Jost, Wolfgang
Kaube, Holger
Kirchhoefer, Ulrike
Kiszka, Michael
Klimpel, Lothar
Koehler, Ulrike
Kollewe, Katja
Kornhuber, Anselm
Krause, Michaela
Krome, Kathrin
Kukowski, Borries
Kupsch, Andreas
Leger, Roland
Lux, Eberhard Albert
Mueller, Gabriele
Mueller-Schwefe, Gerhard
Nautscher-Timmermann, Stephan
JOURNAL OF HEADACHE AND PAIN, 2019, 20 (1):
[43] An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
Fayyaz Ahmed
Charly Gaul
Juan Carlos García-Moncó
Katherine Sommer
Paolo Martelletti
The Journal of Headache and Pain, 2019, 20
[44] Effectiveness of Galcanezumab vs. Traditional Oral Migraine Preventive Medications: Interim 3-Month Results from Real-World TRIUMPH Study
Lipton, R.
Lainez, M.
Ahmed, Z.
Kurth, T.
Vincent, M.
Novick, D.
Vallarino, C.
Viktrup, L.
Robinson, R.
HEADACHE, 2023, 63 : 129 - 130
[45] Effectiveness of galcanezumab vs. traditional oral migraine preventive medications: interim 3-Month results from real-world TRIUMPH study
Lipton, R. B.
Lainez, M.
Ahmed, Z.
Kurth, T.
Vincent, M.
Novick, D.
Vallarino, C.
Viktrup, L.
Robinson, R. L.
JOURNAL OF HEADACHE AND PAIN, 2024, 25
[46] Early Complications After Mild to Moderate Ischemic Stroke and Impact on 3-Month Outcome: The Multicenter Prospective Stroke Unit Plus Cohort Study
Sobesky, Jan
Madai, Vince Istvan
Zweynert, Sarah
Malsch, Carolin
Nabavi, Darius Guenther
Audebert, Heinrich J.
Kleinschnitz, Christoph
Mackert, Bruno Marcel
Schmitz, Bettina
Wollenweber, Frank Arne
Haeusler, Karl Georg
Wellwood, Ian
Wiedmann, Silke
Endres, Matthias
Dirnagl, Ulrich
Meisel, Andreas
Heuschmann, Peter Ulrich
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (04):
[47] A Retrospective Real-Life Multicenter Study on Concurrent Oral Preventive Treatments in Patients with Chronic Migraine Treated with OnabotulinumtoxinA
Overeem, Lucas Hendrik
Ornello, Raffaele
Pocora, Maria Magdalena
Reuter, Uwe
Sacco, Simona
Tassorelli, Cristina
Dueland, Aud Nome
Raffaelli, Bianca
Martinelli, Daniele
CNS DRUGS, 2023, 37 (05) : 453 - 465
[48] A retrospective real-life multicenter study on concurrent oral preventives in patients with chronic migraine treated with botulinum toxin
Overeem, L. H.
Ornello, R.
Pocora, M. M.
Dueland, A. N.
Sacco, S.
Tassorelli, C.
Reuter, U.
Raffaelli, B.
Martinelli, D.
JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
[49] A Retrospective Real-Life Multicenter Study on Concurrent Oral Preventive Treatments in Patients with Chronic Migraine Treated with OnabotulinumtoxinA
Lucas Hendrik Overeem
Raffaele Ornello
Maria Magdalena Pocora
Uwe Reuter
Simona Sacco
Cristina Tassorelli
Aud Nome Dueland
Bianca Raffaelli
Daniele Martinelli
CNS Drugs, 2023, 37 : 453 - 465
[50] Role of integrin expression in the prediction of response to vedolizumab: A prospective real-life multicentre cohort study
De Galan, Cara
Gonzales, Gerard Bryan
Van Welden, Sophie
Tavernier, Simon Jan
Lobaton, Triana
Van Moerkercke, Wouter
Strubbe, Beatrijs
Peeters, Harald
Macken, Elisabeth
De Vos, Martine
Laukens, Debby
Hindryckx, Pieter
CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (04):

← 1 2 3 4 5 →